印度45岁及以上成人糖尿病的患病率、知晓率、治疗率与控制率:一项全国代表性调查
城市患病率30·0%约为农村15·0%的两倍。总体知晓率为60·1%,已诊断者中血糖控制率45·7%、血压控制率58·9%、服用降脂药者仅6·4%。
要点
- 城市患病率30·0%约为农村15·0%的两倍,男性19·6%与女性20·1%相近。
- 已诊断糖尿病患者中血糖控制率45·7%、血压控制率58·9%,服降脂药者仅6·4%。
核心结论
- 研究结果强调印度亟需扩大针对中老年人群的糖尿病预防、发现、管理和控制政策。
研究设计与样本
- 横断面全国代表性调查,纳入2017至2019年印度45岁及以上成人及其配偶,样本57 810人,覆盖36个邦和联邦属地。
- 分析对象为有糖化血红蛋白(HbA1c)测量数据且糖尿病诊断、家庭经济状况和BMI信息完整的参与者,45岁以下配偶被排除。
- 糖尿病患病率定义为自报既往糖尿病诊断或HbA1c≥6·5%;现有数据无法区分1型与2型糖尿病。
主要发现
- 男性患病率19·6%(95%CI 19·0-20·2),女性20·1%(95%CI 19·5-20·6);城市患病率30·0%(95%CI 29·1-30·8)约为农村15·0%(95%CI 14·6-15·5)的两倍。
- 经济发展水平较高的邦年龄标化患病率趋于更高:人均国内生产总值标准化回归系数为0·65(95%CI 0·45-0·85)。
- 总体知晓率为60·1%(95%CI 59·0-61·2);已诊断糖尿病患者中,血糖控制(HbA1c<7·0%)率45·7%(95%CI 44·3-47·2),血压控制(<140/90 mm Hg)率58·9%(95%CI 57·5-60·4),自报使用降脂药者6·4%(95%CI 5·8-7·2)。
关键数值与推荐
- 糖尿病患病率:自报既往诊断或HbA1c≥6·5%。
- 知晓:糖尿病患者中已诊断者所占比例,总体为60·1%(95%CI 59·0-61·2)。
- 血糖控制:已诊断糖尿病患者中HbA1c<7·0%者占45·7%(95%CI 44·3-47·2)。
- 血压控制:已诊断糖尿病患者中血压<140/90 mm Hg者占58·9%(95%CI 57·5-60·4)。
- 治疗:已诊断糖尿病患者中自报使用降脂药者占6·4%(95%CI 5·8-7·2)。
临床怎么用
- 原文未据此给出针对临床实践的推荐。
局限性
- 现有数据无法区分1型与2型糖尿病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: India is a country of 1·4 billion people that contributes to much of the global diabetes burden. Updated evidence on the state of the diabetes epidemic among middle-aged and older adults is imperative given that the risk of diabetes increases with age and that clinical and public health interventions can prevent diabetes complications. We aimed to estimate the prevalence, awareness, treatment, and control of diabetes in a nationally representative and state-representative sample of Indians aged 45 years and older. METHODS: We conducted a cross-sectional, nationally representative survey of adults in India aged 45 years and older and their spouses from 2017 to 2019. Our sample included 57 810 individuals and their spouses from 36 states and union territories, reflecting a representative sample of India as a nation and of each state and union territory. Participants had available data on glycated haemoglobin (HbA1c) measurement and non-missing information on diabetes diagnosis, household economic status, and BMI. Spouses younger than 45 years were excluded from the analysis. Our primary outcomes were diabetes prevalence and health service indicators recommended by WHO. Diabetes prevalence was defined as individuals self-reporting a previous diabetes diagnosis or having HbA1c of 6·5% or higher. Available data did not allow the identification of type 1 versus type 2 diabetes. Diabetes health service indicators were based on four core metrics recommended by WHO: (1) proportion diagnosed out of all individuals with diabetes (awareness) and, out of individuals with diagnosed diabetes, (2) proportion with glycaemic control (measured HbA1c <7·0%), (3) proportion with blood pressure control (measured blood pressure <140/90 mm Hg), and (4) proportion self-reporting use of lipid-lowering medications. Outcomes were assessed in the national sample; by state and union territory; and across individual-level characteristics of age, sex, rural versus urban area of residence, education, economic status, and BMI. FINDINGS: Diabetes prevalence among adults aged 45 years and older in India was 19·8% (95% CI 19·4-20·2), which amounted to 50·4 million people (49·4-51·4). Prevalence among men and women was similar (men, 19·6% [95% CI 19·0-20·2] and women, 20·1% [19·5-20·6]). Urban diabetes prevalence (30·0% [95% CI 29·1-30·8]) was approximately twice as high as rural prevalence (15·0% [14·6-15·5]). States with higher levels of economic development tended to have greater age-standardised prevalence (standardised regression coefficient for gross domestic product per capita 0·65 [95% CI 0·45-0·85]). Overall, 60·1% (59·0-61·2) of individuals were aware of their diabetes. Of individuals with diagnosed diabetes, 45·7% (44·3-47·2) achieved glycaemic control, 58·9% (57·5-60·4) achieved blood pressure control, and 6·4% (5·8-7·2) were taking a lipid-lowering medication. INTERPRETATION: Our findings emphasise the urgent need to scale up policies to better prevent, detect, manage, and control diabetes among middle-aged and older adults in India. FUNDING: US National Institute on Aging; Ministry of Health and Family Welfare, Government of India.
引用
- Sekher TV, Flood D, Green H, et al. Prevalence, awareness, treatment, and control of diabetes in India: a nationally representative survey of adults aged 45 years and older. Lancet Glob Health. 2025. PMID: 40784358. doi:10.1016/S2214-109X(23)00502-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。